Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian CancerAdnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorderNot yet recruitingPhase 1 / Phase 22026-07-10NCT07637851

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
ARCAGY/ GINECO GROUP14
Regeneron Pharmaceuticals238

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre Eugène MarquisRennesFrance42
Centre François BaclesseCaenFrance40
Centre Georges François LeclercDijonFrance42
Centre Léon BérardLyonFrance77
Gustave RoussyVillejuifFrance119
HCL - Centre Hospitalier Lyon SudPierre-BéniteFrance2
Hôpital de HautepierreStrasbourgFrance4
ICM Val d'AurelleMontpellierFrance19
ICO - Centre René GauducheauSaint-HerblainFrance5
Institut BergoniéBordeauxFrance53
Institut Paoli CalmettesMarseilleFrance38